About Alloplex Biotherapeutics
Alloplex Biotherapeutics is a private company based in Woburn, Massachusetts. It has reported $21,070,582 raised in three offerings on Form D since January 2019. Its chief executive is Francescopalo Borriello.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 27, 2023 | Feb 13, 2023 | $20,670,582of $25.0M target | 51 | $405K | Equity, Includes conversion of NotesRule 506(b) | Form D ↗ |
| Jul 17, 2019 | Jul 26, 2019 | $200,000target not set | 2 | $100K | DebtRule 506(b) | Form D ↗ |
| Dec 18, 2018 | Jan 2, 2019 | $200,000of $2.0M target | 2 | $100K | DebtRule 506(b) | Form D ↗ |
| Total, three offerings | $21,070,582 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alloplex Biotherapeutics's Form D filed Feb 13, 2023.
FB
Francescopalo Borriello
Chief Executive Officer
Earlier filings also listed Francescopaolo Borriello (chief executive officer and director, last listed Jul 2019).